Taking these data into consideration, the significant effect of the NR1I2 rs1054190-TT genotype on patient survival in the present study was probably the consequence of broad and multifactorial involvement of PXR in CRC biology and pharmacology. The gene discussed is NR1I2; the disease is colorectal carcinoma.